CXCL8 and arthritic joint disease: In contrast, the pro‐inflammatory agonist serum amyloid A induces release of IL‐8 (CXCL8) and MMP3, and subsequent NF‐κB pathway activation, known to be important modulators of arthritis (Sodin‐Semrl et al., 2004).